4//SEC Filing
Pine Michael Craig 4
Accession 0001562180-24-000400
CIK 0001314102other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 9:11 PM ET
Size
13.7 KB
Accession
0001562180-24-000400
Insider Transaction Report
Form 4
Pine Michael Craig
Chief Corp Dev.&Strat. Officer
Transactions
- Exercise/Conversion
Common Stock
2024-01-06+15,285→ 19,628 total - Tax Payment
Common Stock
2024-01-06$20.40/sh−5,966$121,706→ 13,662 total - Award
Restricted Stock Units
2024-01-05+21,000→ 21,000 totalExercise: $0.00Exp: 2034-01-05→ Common Stock (21,000 underlying) - Exercise/Conversion
Restricted Stock Units
2024-01-06−15,285→ 30,570 totalExercise: $0.00Exp: 2033-06-19→ Common Stock (15,285 underlying) - Award
Stock Option (Right to Buy)
2024-01-05+42,000→ 42,000 totalExercise: $20.40Exp: 2034-01-04→ Common Stock (42,000 underlying)
Footnotes (4)
- [F1]No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units
- [F2]The restricted stock units will vest in three ratable annual installments beginning January 5, 2025.
- [F3]The option to purchase will vest and become exercisable as follows: 25% at January 5th, 2025 and the remainder ratably, on a monthly basis, over the remaining three years.
- [F4]The restricted stock units vests in three ratable annual installments beginning January 6, 2024.
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
Related Parties
1- filerCIK 0001904458
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 9:11 PM ET
- Size
- 13.7 KB